4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0000914190-21-000183
Pres. Diagnostics & Genom sold 811 shares at $433.00 ($351,163)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kelderman Kim Pres. Diagnostics & Genom | 2021-06-09 | Sale | −811 | $433.00 | $351,163 | 0 | D: show line 1 in the form |
| Open-market sales · 811 sh · avg $433.00 · $351,163 | |||||||
Loading xslF345X03/edgar.xml…